Genetic biomarkers could personalise therapy for TNBC
Drug Discovery World
AUGUST 16, 2023
A new study has shed light on the genetic messages encoded by genes within ‘triple negative’ breast cancers (TNBC), and shows they could predict response to chemotherapy. The presence of these biomarkers could be used to accelerate the development of more personalised treatments for triple negative breast cancers.
Let's personalize your content